Dosage Form Formulation Technologies for Improving Bioavailability
This Special Issue welcomed original research papers, but was not limited to cooperative works between academia and pharmaceutical companies where reformulations or original dosage form designs were performed. Papers or reviews including the principles of Quality by Design to improve the bioavailabi...
Gespeichert in:
| Format: | Online |
|---|---|
| Sprache: | Englisch |
| Veröffentlicht: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Schlagworte: | |
| Online-Zugang: | ONIX_20240906_9783725815708_121 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
| _version_ | 1869531107209248768 |
|---|---|
| collection | Directory of Open Access Books |
| description | This Special Issue welcomed original research papers, but was not limited to cooperative works between academia and pharmaceutical companies where reformulations or original dosage form designs were performed. Papers or reviews including the principles of Quality by Design to improve the bioavailability of drugs belonging to BCS Classes of II or IV were warmly encouraged for submission. We were looking for manuscripts that optimized innovative technology through the design of experiments as well. Non-pharma institutes or departments and their innovative research projects were also invited to contribute to this Special Issue if their novel and original results could be adapted to dosage form formulation or production. |
| format | Online |
| id | doab-20.500.12854ir-143759 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1437592024-09-06T08:19:30Z Dosage Form Formulation Technologies for Improving Bioavailability Vasvári, Gábor Haimhoffer, Ádám periodontal pocket drug delivery poloxamer 407 hyaluronic acid periodontitis thermoresponsive niosome gel hydroxytyrosol pharmaceutical formulation pharmacokinetics bioavailability DOPET DOPAC MOPET HVA human volunteers centrifugal spinning microfibre amorphous solid dispersion sucrose poorly water-soluble drug itraconazole dissolution enhancement supersaturation tabletting oral formulation in vitro methods cell culture ex vivo methods cannabidiol cannabidiolic acid cannabichromene cannabis solubility permeability in situ forming nanoparticles parenteral targeted drug delivery design of experiment PDLG cholesterol PBPK lipid polymer calcium carbonate CaCO3 particles vaterite metastability recrystallization calcite degradation dissolution pH-sensitivity resorption biodegradation controlled release ayer-by-layer assembly calcium ions carbon dioxide bubbles ossification theranostics anticancer therapy antimicrobial therapy US imaging cavitation buffering fast-dissolving film rosuvastatin hyperlipidemia design of experiment approach lipid-based formulations bioavailability enhancement anticancer protein kinase CK2 CK2 inhibitor DMAT alginate microbeads Transcutol® HP polyvinylpyrrolidone BGP-15 Box–Behnken design of experiment penetration enhancers transdermal patches PVA PVP in vitro permeation porcine skin microbead oral bioavailability absorption enhancement Labrasol ALF Labrafil M 2125 CS Caco-2 cells thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing This Special Issue welcomed original research papers, but was not limited to cooperative works between academia and pharmaceutical companies where reformulations or original dosage form designs were performed. Papers or reviews including the principles of Quality by Design to improve the bioavailability of drugs belonging to BCS Classes of II or IV were warmly encouraged for submission. We were looking for manuscripts that optimized innovative technology through the design of experiments as well. Non-pharma institutes or departments and their innovative research projects were also invited to contribute to this Special Issue if their novel and original results could be adapted to dosage form formulation or production. 2024-09-06T08:19:22Z 2024-09-06T08:19:22Z 2024 book ONIX_20240906_9783725815708_121 9783725815708 9783725815692 https://directory.doabooks.org/handle/20.500.12854/143759 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/9481 https://mdpi.com/books/pdfview/book/9481 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-1569-2 10.3390/books978-3-7258-1569-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725815708 9783725815692 open access |
| spellingShingle | periodontal pocket drug delivery poloxamer 407 hyaluronic acid periodontitis thermoresponsive niosome gel hydroxytyrosol pharmaceutical formulation pharmacokinetics bioavailability DOPET DOPAC MOPET HVA human volunteers centrifugal spinning microfibre amorphous solid dispersion sucrose poorly water-soluble drug itraconazole dissolution enhancement supersaturation tabletting oral formulation in vitro methods cell culture ex vivo methods cannabidiol cannabidiolic acid cannabichromene cannabis solubility permeability in situ forming nanoparticles parenteral targeted drug delivery design of experiment PDLG cholesterol PBPK lipid polymer calcium carbonate CaCO3 particles vaterite metastability recrystallization calcite degradation dissolution pH-sensitivity resorption biodegradation controlled release ayer-by-layer assembly calcium ions carbon dioxide bubbles ossification theranostics anticancer therapy antimicrobial therapy US imaging cavitation buffering fast-dissolving film rosuvastatin hyperlipidemia design of experiment approach lipid-based formulations bioavailability enhancement anticancer protein kinase CK2 CK2 inhibitor DMAT alginate microbeads Transcutol® HP polyvinylpyrrolidone BGP-15 Box–Behnken design of experiment penetration enhancers transdermal patches PVA PVP in vitro permeation porcine skin microbead oral bioavailability absorption enhancement Labrasol ALF Labrafil M 2125 CS Caco-2 cells thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing Dosage Form Formulation Technologies for Improving Bioavailability |
| title | Dosage Form Formulation Technologies for Improving Bioavailability |
| title_full | Dosage Form Formulation Technologies for Improving Bioavailability |
| title_fullStr | Dosage Form Formulation Technologies for Improving Bioavailability |
| title_full_unstemmed | Dosage Form Formulation Technologies for Improving Bioavailability |
| title_short | Dosage Form Formulation Technologies for Improving Bioavailability |
| title_sort | dosage form formulation technologies for improving bioavailability |
| topic | periodontal pocket drug delivery poloxamer 407 hyaluronic acid periodontitis thermoresponsive niosome gel hydroxytyrosol pharmaceutical formulation pharmacokinetics bioavailability DOPET DOPAC MOPET HVA human volunteers centrifugal spinning microfibre amorphous solid dispersion sucrose poorly water-soluble drug itraconazole dissolution enhancement supersaturation tabletting oral formulation in vitro methods cell culture ex vivo methods cannabidiol cannabidiolic acid cannabichromene cannabis solubility permeability in situ forming nanoparticles parenteral targeted drug delivery design of experiment PDLG cholesterol PBPK lipid polymer calcium carbonate CaCO3 particles vaterite metastability recrystallization calcite degradation dissolution pH-sensitivity resorption biodegradation controlled release ayer-by-layer assembly calcium ions carbon dioxide bubbles ossification theranostics anticancer therapy antimicrobial therapy US imaging cavitation buffering fast-dissolving film rosuvastatin hyperlipidemia design of experiment approach lipid-based formulations bioavailability enhancement anticancer protein kinase CK2 CK2 inhibitor DMAT alginate microbeads Transcutol® HP polyvinylpyrrolidone BGP-15 Box–Behnken design of experiment penetration enhancers transdermal patches PVA PVP in vitro permeation porcine skin microbead oral bioavailability absorption enhancement Labrasol ALF Labrafil M 2125 CS Caco-2 cells thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing |
| topic_facet | periodontal pocket drug delivery poloxamer 407 hyaluronic acid periodontitis thermoresponsive niosome gel hydroxytyrosol pharmaceutical formulation pharmacokinetics bioavailability DOPET DOPAC MOPET HVA human volunteers centrifugal spinning microfibre amorphous solid dispersion sucrose poorly water-soluble drug itraconazole dissolution enhancement supersaturation tabletting oral formulation in vitro methods cell culture ex vivo methods cannabidiol cannabidiolic acid cannabichromene cannabis solubility permeability in situ forming nanoparticles parenteral targeted drug delivery design of experiment PDLG cholesterol PBPK lipid polymer calcium carbonate CaCO3 particles vaterite metastability recrystallization calcite degradation dissolution pH-sensitivity resorption biodegradation controlled release ayer-by-layer assembly calcium ions carbon dioxide bubbles ossification theranostics anticancer therapy antimicrobial therapy US imaging cavitation buffering fast-dissolving film rosuvastatin hyperlipidemia design of experiment approach lipid-based formulations bioavailability enhancement anticancer protein kinase CK2 CK2 inhibitor DMAT alginate microbeads Transcutol® HP polyvinylpyrrolidone BGP-15 Box–Behnken design of experiment penetration enhancers transdermal patches PVA PVP in vitro permeation porcine skin microbead oral bioavailability absorption enhancement Labrasol ALF Labrafil M 2125 CS Caco-2 cells thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing |
| url | ONIX_20240906_9783725815708_121 |